Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group
about
Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement.Nodular lymphocyte predominant Hodgkin lymphoma in Sweden between 2000 and 2014: an analysis of the Swedish Lymphoma Registry.[Treatment of low-risk pediatric lymphocyte-predominant Hodgkin lymphoma].Variant histology, IgD and CD30 expression in low-risk pediatric nodular lymphocyte predominant Hodgkin lymphoma: A report from the Children's Oncology Group.Hodgkin lymphoma: A review and update on recent progress.Surgeon Concordance in the Assessment of Resectability for Stage IA Nodular Lymphocyte Predominant Hodgkin Lymphoma.
P2860
Minimal Treatment of Low-Risk, Pediatric Lymphocyte-Predominant Hodgkin Lymphoma: A Report From the Children's Oncology Group
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Minimal Treatment of Low-Risk, ...... the Children's Oncology Group
@en
Minimal Treatment of Low-Risk, ...... the Children's Oncology Group.
@nl
type
label
Minimal Treatment of Low-Risk, ...... the Children's Oncology Group
@en
Minimal Treatment of Low-Risk, ...... the Children's Oncology Group.
@nl
prefLabel
Minimal Treatment of Low-Risk, ...... the Children's Oncology Group
@en
Minimal Treatment of Low-Risk, ...... the Children's Oncology Group.
@nl
P2093
P2860
P356
P1476
Minimal Treatment of Low-Risk, ...... the Children's Oncology Group
@en
P2093
Allen B Buxton
Burton E Appel
Cindy L Schwartz
David C Hodgson
Louis S Constine
Peter F Ehrlich
Robert E Hutchison
P2860
P304
P356
10.1200/JCO.2015.65.3469
P407
P577
2016-05-16T00:00:00Z